|
Purdue Pharma helps patients stay ahead of the pain -- and the constipation that comes with opiate use. The company specializes in developing, manufacturing, and marketing sustained-release and long-acting treatments for chronic and severe pain. Its opioid drugs for pain relief include controlled-release analgesics OxyContin (a version of oxycodone), Ryzolt (tramadol), and morphine drug MS Contin. The company continues to develop and commercialize new products through alliances with such companies as Transcept and Labopharm. Purdue also sells a number of non-prescription products including topical antiseptic Betadine and the Colace and Senokot lines of laxatives. Purdue Pharma operates in the US.
|
| | | Contact Information | |
Address: |
1 Stamford Forum, 201 Tresser Blvd.
Stamford, CT 06901-3431
| | Phone: | 203-588-8000 | | Fax: | 203-588-8850 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 102.30 M | | Employees (2008): | 805 |
|
|
Key People
| | • |
President and CEO Purdue Pharma lP (USA):
John H. Stewart
| | • |
EVP and CFO:
Edward B. (Ed) Mahony
| | • |
VP IT Administration and CIO:
Larry Pickett
|
|
|
